Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FLUDEOXYGLUCOSE F-18 vs FLUNITRAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FLUDEOXYGLUCOSE F-18 vs FLUNITRAZEPAM: Safety Overview

Metric FLUDEOXYGLUCOSE F-18 FLUNITRAZEPAM
Total FAERS Reports 139 944
Deaths Reported 14 285
Death Rate 10.1% 30.2%
Hospitalizations 49 442
Average Patient Age 62.7 yrs 47.9 yrs
% Female Patients 49.6% 51.9%
FDA Approval Date Apr 11, 2016 N/A
Manufacturer BRIGHAM AND WOMEN`S HOSPITAL, INC., THE N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A